Journal
FRONTIERS IN AGING NEUROSCIENCE
Volume 14, Issue -, Pages -Publisher
FRONTIERS MEDIA SA
DOI: 10.3389/fnagi.2022.847386
Keywords
microglia; injury; inflammation; delta-opioid receptor; lipopolysaccharide; hypoxia
Categories
Funding
- National Natural Science Foundation of China [81873361, 82101533, 81870906]
- Young Talent Development Plan of Changzhou Health Commission [CZQM2020043]
- Science and Technology Commission of Shanghai Municipality [18401970100]
- Key projects of Jiangsu Commission of Health [ZD2021027]
- Science and Technology Guide Project of Changzhou Health Commission [CE20205025]
Ask authors/readers for more resources
Microglia play an important role in regulating cerebral homeostasis and combating pathogens. Excessive activation of microglia has been implicated in various age-related cerebral diseases. Microglia can undergo complex polarization changes, which can exacerbate or alleviate cellular injury. Delta-opioid receptor (DOR) activation has a protective effect against neuronal injuries, and our study suggests that DOR expression/function is closely linked to microglial polarization and plays a critical role in controlling microglial activation. These findings provide new insights into protective strategies against neurodegenerative pathologies through DOR-mediated regulation of microglia.
Microglia are involved in the regulation of cerebral homeostasis and pathogen confrontation. There is, however, evidence showing that excessive microglia activation is implicated in various age-related cerebral diseases. On the other hand, microglia may experience complex changes of polarization in pathological insults, i.e., from a proinflammatory M1 to an anti-inflammatory M2 phenotype, which differentially contribute to the exacerbation or alleviation of cellular injury. Remolding the phenotype of microglia or inhibiting the excessive activation of microglia seems to be a promising approach against neurodegenerative pathologies. Since delta-opioid receptor (DOR) activation exhibits a strong protective capacity against various neuronal injuries, especially the hypoxic/ischemic injury, we asked if the DOR-induced neuroprotection is associated with its effect on microglia. We explored this fundamental issue by using pharmacological and genetic approaches in the BV2 cell line, a general type of microglial cells. The results showed that DOR expression significantly increased in the activated microglial M2 phenotype, but slightly decreased in the microglial M1 phenotype. Hypoxia induced dual polarizations of BV2 cells with an increase in DOR expression. Administration of a specific DOR agonist, UFP-512, largely inhibited lipopolysaccharide (LPS) or hypoxia-induced microglial M1 activation and inflammatory activity with high concentrations of UFP-512 being effective to reverse the interleukin-4 (IL4)-induced microglial activation. Consistent with these observations, inhibiting DOR or knocking-down DOR promoted the excessive activation of BV2 cells in both M1 and M2 directions, while DOR overexpression did the opposite. Furthermore, the PC12 cells exposed to the conditioned medium of BV2 cells treated by UFP-512 grew better than those treated directly with UFP-512 under LPS or hypoxic insults. DOR inhibitor naltrindole could block all the effects of DOR activation. The medium from the BV2 cells with DOR knock-down decreased the viability of PC12 cell, while the medium from the BV2 cells with DOR overexpression largely attenuated LPS or hypoxic injury in the PC12 cells. These first data suggest a close linkage between DOR expression/function and microglial polarization and a critical role of DOR in negative controlling microglial activation. Our work provides a novel clue for new protective strategies against neurodegenerative pathophysiology through DOR-mediated regulation of microglia.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available